Canadian Journal of Gastroenterology (Jan 2003)

Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis

  • Murat Kiyici,
  • Macit Gulten,
  • Selim Gurel,
  • Selim Giray Nak,
  • Enver Dolar,
  • Gursel Savci,
  • Saduman Balaban Adim,
  • Omer Yerci,
  • Faruk Memik

DOI
https://doi.org/10.1155/2003/857869
Journal volume & issue
Vol. 17, no. 12
pp. 713 – 718

Abstract

Read online

BACKGROUND/AIMS: Nonalcoholic steatohepatitis (NASH) is a serious disorder with the potential to gradually progress to cirrhosis. It is generally associated with obesity, diabetes and hyperlipidemia. Currently, there is no established therapy for NASH. The aim of the present study was to evaluate the effectiveness of atorvastatin and ursodeoxycholic acid (UDCA) in the treatment of NASH.